Is now at
Argyll Park, Dixon, California
Argyll 

Home

The trial will enroll up to 1000 patients and is currently being executed in Japan.

The trial will enroll up to 1000 patients and is currently being executed in Japan, Hong Kong, Korea, Taiwan, Italy, america and Canada priligyreview.net/super-p-force.html . In addition to China, Celsion expects to get CTA acceptance in Thailand, Malaysia, and the Philippines during the fourth one fourth of 2009 and will have got up to sixty sites activated by the finish of the entire year. Completion of patient enrollment is expected to happen in the initial half of 2010. The expansion of the trial to China not only accelerates patient enrollment, but builds on our global strategy to conduct our Stage III trial in areas where in fact the incidence of HCC is significant.